Innovative Eyewear Inc 10-Q for FY2022 Q3
Innovative Eyewear Inc (LUCY)
About this 10-Q
Innovative Eyewear Inc filed this 10-Q on November 10, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $151.96K
- down 11.2% from $171.03K a year earlier
- Net loss
- $1.4M
- compared with a net loss of $1.1M a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark one)
For
the quarterly period ended
For the transition period from __________ to __________
Commission
file number
| (Exact name of registrant as specified in its charter) |
| (State
or other jurisdiction of incorporation or organization) |
(I.R.S.
Employer Identification No.) |
| (Address of Principal Executive Offices, including zip code) |
| (Registrant’s telephone number, including area code) |
| Not Applicable |
| (Former name, former address and former fiscal year, if changed since last report) |
Indicate
by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days.
Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant
was required to submit such files.)
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ |
| ☒ | Smaller Reporting Company | ||
| Emerging growth company |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The
| ||||
| The
|
As of November 9, 2022, there were shares of the Company’s common stock issued and outstanding.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
The discussions in this Quarterly Report on Form 10-Q contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. These forward-looking statements include, but are not limited to, statements concerning any potential future impact of the coronavirus disease (“COVID-19”) pandemic on our business, supply chain constraints, our strategy, competition, future operations and production capacity, future financial position, future revenues, projected costs, profitability, expected cost reductions, capital adequacy, expectations regarding demand and acceptance for our technologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management. The words “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in this Quarterly Report on Form 10-Q and in our other filings with the Securities and Exchange Commission (the “SEC”). We do not assume any obligation to update any forward-looking statements.
Innovative Eyewear, Inc.
Table of Contents
i
Unless specifically set forth to the contrary, when used in this report the terms “Innovative Eyewear,” “Lucyd,” the “Company,” “we,” “our,” “us,” and similar terms refer to Innovative Eyewear, Inc. The information which appears on our website lucyd.co is not part of this report.
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
INNOVATIVE EYEWEAR, INC.
CONDENSED BALANCE SHEETS
September 30, 2022 (Unaudited) and December 31, 2021
| 2022 | 2021 | |||||||
| TOTAL ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Accounts receivable | ||||||||
| Prepaid expenses | ||||||||
| Deferred offering costs | ||||||||
| Inventory prepayment | ||||||||
| Inventory | ||||||||
| Other current assets | ||||||||
| Total Current Assets | ||||||||
| Non-Current Assets | ||||||||
| Patent costs, net | ||||||||
| Capitalized software costs | ||||||||
| Property and equipment, net | ||||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued expenses | $ | $ | ||||||
| Due to Parent and Affiliates | ||||||||
| Related party convertible debt | ||||||||
| Total Current Liabilities | ||||||||
| TOTAL LIABILITIES | ||||||||
| Commitments and contingencies | ||||||||
| Stockholders’ Equity | ||||||||
| Common stock (par value $, shares authorized, and and shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively) | ||||||||
| Additional paid-in capital | ||||||||
| Stock subscription receivable | ( | ) | ( | ) | ||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ | ||||||
See accompanying Notes to the Financial Statements.
1
INNOVATIVE EYEWEAR, INC.
CONDENSED STATEMENTS OF OPERATIONS
For the three and nine months ended September 30, 2022 and 2021
(Unaudited)
| Three
Months Ended September 30, | Nine
Months Ended September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Revenues, net | $ | $ | $ | $ | ||||||||||||
| Less: Cost of Goods Sold | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Gross Profit | ||||||||||||||||
| Operating Expenses: | ||||||||||||||||
| General and administrative | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Sales and marketing | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Research & development | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Related party management fee | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Total Operating Expenses | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other Expense | ( | ) | ( | ) | ||||||||||||
| Interest Expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Total Other Expenses | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average number of shares outstanding | ||||||||||||||||
| Earnings per share, basic and diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
See accompanying Notes to the Financial Statements.
2
INNOVATIVE EYEWEAR, INC.
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
For the three and nine months ended September 30, 2022 and 2021
(Unaudited)
| Common Stock | Additional Paid-in | Stock Subscription | Accumulated | Total Stockholders’ Equity | ||||||||||||||||||||
| Shares | Amount | Capital | Receivable | Deficit | (Deficit) | |||||||||||||||||||
| Balances, January 1, 2022 | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||
| Net Loss | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | |||||||||||||||||||||||
| Balances, March 2022 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | |||||||||||||||||||||||
| Collection of stock subscription receivable | - | |||||||||||||||||||||||
| Balances, June 30, 2022 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||||||||||
| Shares issued for convertible note exercise | ||||||||||||||||||||||||
| Initial public offering (see Note 10) | ||||||||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | |||||||||||||||||||||||
| Balances, September 30, 2022 | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||
| Balances, January 1, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||||||||||
| Issuance of shares net of offering costs of $217,958 | ( | ) | ||||||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | |||||||||||||||||||||||
| Balances, March 2021 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||||||||||
| Shares issued for convertible note exercise | ||||||||||||||||||||||||
| Issuance of shares, net of offering costs of $28,230 | ( | ) | ||||||||||||||||||||||
| Stock based compensation | - | |||||||||||||||||||||||
| Collection of stock subscription receivable | - | |||||||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||||||
| Balances, June 30, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||
| Shares issued for convertible note exercise | ||||||||||||||||||||||||
| Issuance of shares, net of offering costs of $93,341 | ( | ) | ||||||||||||||||||||||
| Stock based compensation | - | |||||||||||||||||||||||
| Net loss | - | ( | ) | ( | ) | |||||||||||||||||||
| Balances, September 30, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | $ |
See accompanying Notes to the Financial Statements.
3
INNOVATIVE EYEWEAR, INC.
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)
For the nine months ended September 30, 2022 and 2021
| 2022 | 2021 | |||||||
| Operating Activities | ||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Amortization | ||||||||
| Depreciation | ||||||||
| Non cash interest expense | ||||||||
| Stock based compensation expense | ||||||||
| Expenses paid by parent and affiliates | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ( | ) | ||||
| Accounts payable and accrued expenses | ||||||||
| Prepaid expenses | ( | ) | ( | ) | ||||
| Inventory | ( | ) | ( | ) | ||||
| Other current assets | ( | ) | ||||||
| Deferred revenue | ||||||||
| Deferred offering costs | ( | ) | ||||||
| Net cash flows from operating activities | ( | ) | ( | ) | ||||
| Investing Activities | ||||||||
| Patent costs | ( | ) | ( | ) | ||||
| Purchases of property and equipment | ( | ) | ( | ) | ||||
| Capitalized software expenditures | ( | ) | ( | ) | ||||
| Net cash flows from investing activities | ( | ) | ( | ) | ||||
| Financing Activities | ||||||||
| Proceeds from issuance of shares, net of offering expenses | ||||||||
| Collection of stock subscription receivable | ||||||||
| Proceeds from related party convertible debt | ||||||||
| Repayment of related party convertible debt | ( | ) | ( | ) | ||||
| Repayments of amounts Due to Parent and Affiliates | ( | ) | ||||||
| Net cash flows from financing activities | ||||||||
| Net Change In Cash | ||||||||
| Cash at Beginning of Period | $ | $ | ||||||
| Cash at End of Period | $ | $ | ||||||
| Significant Non-Cash Transaction | ||||||||
| Expenses paid for by Parent reported as increase in Due to Parent and Affiliates and related party convertible debt | ||||||||
| Shares issued from conversion of related party convertible debt | ||||||||
See accompanying Notes to the Financial Statements.
4
INNOVATIVE EYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 2022 and 2021 (Unaudited)
NOTE 1 – GENERAL INFORMATION
Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd. (the “Parent” or “Lucyd”), a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, the “Parent and Affiliates”), which currently owns approximately 71% of our issued and outstanding shares of common stock. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying condensed balance sheet as of December 31, 2021 (which has been derived from audited financial statements) and the unaudited interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.
In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the periods presented have been included. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for future periods or the full year.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant social and economic disruptions and uncertainties associated with the ongoing coronavirus pandemic (“COVID-19”) and COVID-19 control responses.
Receivables and Credit Policy
Trade
receivables from customers are uncollateralized customer obligations due under normal trade terms, primarily requiring payment before
product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to
the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice.
The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net
30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is
provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for
much we will bill the customer via credit card. As a result, the Company believes that its accounts receivable credit risk exposure is
limited, and it has not experienced any significant write-downs in its accounts receivable balances. As of September 30, 2022, and December
31, 2021, the Company had
Capitalized Software
The Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the software. We expect an estimated useful life of five years for this product.
5
Inventory
Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of September 30, 2022 and as of December 31, 2021.
As
of September 30, 2022 and December 31, 2021, the Company recorded an inventory prepayment in the amount of $
Intangible Assets
Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents.
The Company reviews its intangibles assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.
Property and Equipment
Property
and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation
expense for the three and nine months ended September 30, 2022, was $
Income Taxes
The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.
The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. The guidance relates to, among other things, classification, accounting for interest and penalties associated with tax positions, and disclosure requirements. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.
The Company assesses the realizability of its net deferred tax assets. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.
Stock-Based Compensation
The Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).
The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.
6
Revenue Recognition
Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.
To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.
All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.
For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.
For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.
For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.
The Company’s sales do not contain any variable consideration.
We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:
| ● | 7 days for sales made through our website (Lucyd.co) |
| ● | 30 days for sales made through Amazon |
| ● | 30 days for sales to wholesale retailers and distributors |
For
all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns,
which is recorded as a reduction of sales. Additionally, we reviewed all individual returns received in October 2022 pertaining
to orders processed prior to September 30, 2022. As a result, the Company determined that an allowance for sales returns was necessary.
The Company recorded $
Shipping and Handling
Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.
7
NOTE 3 – LIQUIDITY AND CAPITAL RESOURCES
The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste including the economic impacts from the COVID-19 pandemic. These adverse conditions could affect the Company’s financial condition and the results of its operations.
The Company meets its day to day working capital requirements through monies raised through sales of eyewear and issuances of equity, including past crowdfunding transactions, and more recently an initial public offering completed on August 2022. The Company also has issued a convertible note held by its parent company. The Company’s forecasts and projections indicate that the Company expects to have sufficient cash reserves and future income to operate within the level of its current facilities. The Company anticipates that its available liquidity will be sufficient to fund operations through at least the end of 2023.
NOTE 4 – INCOME TAX PROVISION
At
the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year. This
estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.
Accordingly, the Company’s effective tax rate for the nine months ended September 30, 2022, was
NOTE 5 – INTANGIBLE ASSETS
| Schedule of intangible assets | ||||||||
| September 30, | December 31, | |||||||
| Finite-lived intangible assets | 2022 | 2021 | ||||||
| Patent Costs | $ | $ | ||||||
| Intangible assets, gross | ||||||||
| Less: Accumulated amortization | ( | ) | ( | ) | ||||
| Intangible assets, net | $ | $ | ||||||
Amortization
expense totaled $
NOTE 6 – RELATED PARTY ADVANCES AND OTHER INTERCOMPANY AGREEMENTS
Convertible Note and Due to Parent and Affiliates
During the nine months ended September 30, 2022 and during 2021, the Company had the availability of, but not the contractual right to, intercompany financing from the Parent and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).
The
convertible notes balances were $
Management Service Agreement
In 2020, the Company entered into a management services agreement with a related party (related through common ownership). The Company is billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.
8
The related party provides the following services:
| ● | Support and advice to the Company in accordance with their area of expertise; |
| ● | Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; |
| ● | Advice, assistance, and consultation services to support the Company or in relation to any other related matter |
During
the three and nine months ended September 30, 2022, the Company incurred $
NOTE 7 – COMMITMENTS AND CONTINGENCIES
Legal Matters
The Company is not currently involved in or aware of threats of any litigation.
Leases
Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are shared with the parent of our majority stockholder, Tekcapital, and the Company is allocated 70% of the monthly rental costs, which is paid by the Parent and recorded as an increase in Due to Parent. We consider our current office space adequate for our current operations.
Commitments
See related party management services agreement discussed in Note 6.
In
July 2022, the Company entered into a license agreement which grants the Company the right to sell certain branded smart eyewear. The
license agreement requires the Company to pay royalties based on a percentage of net retail and wholesale sales, as defined. The license
agreement has a base term of
No option awards were granted during the nine months ended September 30, 2022.
Details of the number of share options and the weighted average exercise price outstanding as of and during the nine months ended September 30, 2022 and are as follows:
| Schedule of stock based compensation activity | ||||||||
| Av.
Exercise price per share | Options | |||||||
| $ | (Number) | |||||||
| As at January 1, 2022 | ||||||||
| Granted | ||||||||
| Exercised | ||||||||
| Forfeited | ||||||||
| As at September 30, 2022 | ||||||||
| Exercisable as at September 30, 2022 | ||||||||
As of September 30, 2022, unrecognized stock option expense of $ remains to be recognized over next years.
9
The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. As of September 30, 2022 and December 31, 2021, all shares underlying the related party convertible debt and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.
Calculation of net earnings per common share — basic and diluted:
| Calculation of net earnings per common share - basic and diluted | ||||||||
| For
the Nine Months Ended | ||||||||
| September 30, 2022 | September 30, 2021 | |||||||
| (In thousands, except per share amounts) | ||||||||
| Basic and diluted: | ||||||||
| Net loss | ( | ) | ( | ) | ||||
| Weighted-average number of common shares | ||||||||
| Basic and diluted net income (loss) per common share | $ | ( | ) | $ | ( | ) | ||
NOTE 10 – INITIAL PUBLIC OFFERING
On
August 17, 2022, the Company closed on its initial public offering of units consisting of shares of its common stock
and 1,960,000 warrants to purchase
The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.
Also,
pursuant to the terms of the underwriting agreement for the offering, the Company issued the underwriter certain other warrants to purchase
up to
The
net proceeds received by the Company at closing amounted to $
NOTE 11 – SUBSEQUENT EVENTS
On November 15, 2022,
the exercise price of the Warrants will adjust to be equal to the greater of $
10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read together with our financial statements and the related notes and the other financial information included elsewhere in this Quarterly Report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Quarterly Report.
Overview
We develop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering vision correction and protection. Our flagship product, Lucyd Lyte, enables the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free. Innovative Eyewear owns the exclusive rights to the Lucyd brand and the Lyte product line.
Our mission is to Upgrade Your Eyewear. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a solution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyle upgrade at a price similar to traditional prescription eyewear.
After the full launch of Lucyd Lyte in January 2021, we had strong interest and demand from customers in the U.S. and have since sold thousands of our smart eyewear products. In order to meet the growing demand for our products, and in an effort to expand our reach, we have engaged over 150 unique wholesale accounts. All of our products are designed in Miami, manufactured in Asia, and currently sold through two major sales channels:
| (1) | e-commerce, primarily via our website (Lucyd.co) and marketplaces such as Amazon, Bestbuy.com, and DicksSportingGoods.com. |
| (2) | a growing network of independent eyewear stores. |
We apply a manufacturer suggested retail price (“MSRP”) of $149 (for our standard frames) to $179 (for our titanium frames) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels, with our wholesale pricing offering volume discounts to these prices. Please refer to discussion in the Components of Results of Operations section below for more details regarding our pricing structure.
We are gearing-up to expand these channels with national eyewear chains, big box retail stores (electronics, sporting goods, general merchandise) and specialty retail stores.
We view this business model as being more efficient with regards to the deployment of capital, by electing not to build our own manufacturing facilities and Company-owned retail distribution, but rather contract with existing sources of production and consumer facing retail distribution.
In July 2022, the Company entered into a license agreement which grants the Company the right to sell certain branded smart eyewear. The license agreement requires the Company to pay royalties based on a percentage of net retail and wholesale sales, as defined. The license agreement has a base term of 10 years but is cancellable at the option of the Company during the fifth year. The license agreement requires guaranteed minimum royalty payments totaling approximately $1 million over the next five years, of which less than $25,000 is due during the 2023 calendar year.
11
Impact of COVID-19 on Our Business
On March 11, 2020, the World Health Organization officially declared the outbreak of the COVID-19 virus a “pandemic.” This contagious disease outbreak has continued to spread across the globe and is impacting worldwide economic activity and financial markets. In light of the uncertain and rapidly evolving situation relating to the spread of COVID-19, we took precautionary measures intended to minimize the risk of the virus to our employees, by following the CDC guidelines. Specifically, we set up a system that enabled our employees to work remotely when it was beneficial for them or when they felt ill. Additionally, precautionary measures that have been adopted may negatively affect our ability to sell our products. This includes, for example, reducing the marketplace traction at trade shows, and retail store traffic for our re-sellers, and the fulfilment of customer orders with customized lenses, shipping delays and other operations of our suppliers and fulfilment partners. Additionally, our product is manufactured in China and shipped from China on a regular basis. We have not experienced substantial delays in manufacturing or shipping due to COVID-19; however, we are exposed to such risk in the future as a potential impact of COVID-19. More generally, the outbreak of COVID-19 could adversely affect economies and financial markets globally, potentially leading to an economic downturn, which could decrease consumer spending and adversely affect demand for our products. It is not possible at this time to estimate the impact that COVID-19 could have on our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.
Key Factors Affecting Performance
Expansion of retail points of purchase
Our future depends in large part on our ability to place Lucyd Lyte in optical stores as well as sporting goods stores and other specialty stores. To address this, we assembled a team with decades of experience in the eyewear industry and are offering a strong co-op marketing program and re-ordering incentives program. We currently have 16 different styles available and plans to continuously increase this number over time.
Retail store client retention and re-orders
Our ability to sustain and increase revenue depends in large part on our ability to receive re-orders from stores, either directly or through our wholesale distributors. To support our sales to retail stores directly, we offer a strong co-op marketing program that includes free and paid store display materials. As part of this strategy, we have launched a digital try-on kiosk for our resellers to help educate their in-store customers about Lucyd Lyte and enable customers to try them on in a contact-less manner, to mitigate customer contact with viral pathogens.
Investing in business growth
We believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about the shape, size, and design of their eyewear, we aim to continuously invest in the design and development of new models in an effort to provide the consumer with a wide selection of styles, colors, and finishes.
We also intend to invest in co-op marketing with retail stores and expand our sales and marketing team (including influencers) to broaden our brand awareness and online presence. We will also increase our general and administrative expenses in the foreseeable future to cover the additional costs for finance, compliance, supply chain, quality assurance, and investor relations as we grow as a public company.
Key Performance Indicators
Store Count (B2B)
We believe that one of the key indicators for our business is the number of retail stores onboarded to sell Lucyd Lyte. We started onboarding our first retail stores in June 2021. Currently, we have over 250 retail stores selling Lucyd Lyte primarily in the United States and Canada.
Based on the existing demand for our products, current distribution, and recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-party retail locations for the remainder of 2022 and 2023.
12
Re-order ratio (B2B)
Many of the retail stores that placed initial stocking orders, either directly or through our wholesale distributors, have also placed follow-on orders in the few short months since launching our wholesale business in June 2021. As of September 30, 2022, 27.7% of stores have re-ordered our product. We expect this number to gradually increase as we roll out our co-op marketing program and introduce more of our virtual try-on kiosks into retail stores, to facilitate customer education and product sell-through.
Number of online orders (B2C)
For our e-commerce business, we track the number of online orders as an indicator of the success of our online marketing efforts. As of September 30, 2022, we received a total of over 10,435 orders from customers online. We believe that the addition of new styles, as well as further investment in brand awareness, product ambassadors, and influencer campaigns, will enable continued growth of online orders in the foreseeable future. We expect to allocate a significant portion of our advertising expenditures towards influencer marketing programs.
Components of Results of Operations
Net Revenue
Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, and on our own website Lucyd.co and on Amazon.
We apply a manufacturer suggested retail price (“MSRP”) of $149 (for our standard frames) to $179 (for our titanium frames) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers. We charge applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which sell.
Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts to the MSRP, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.
Our prescription lens prices range from $35 for a basic clear single vision lens, up to $415 for a Transitions® progressive signature colorized lens, which is charged in addition to the MSRP. Glasses with prescription lenses are only available through our website Lucyd.co, while our sales through Amazon and to our retail partners only include non-prescription glasses.
Cost of Goods Sold
Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.
For retail sales placed on one of our e-commerce channels, these costs include (i) product costs held at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, (iii) optical laboratory costs for RX glasses, (iv) merchant fees, (v) fees paid to third-party e-commerce platforms, and (vi) cost of shipping the product to the consumer.
For wholesale sales these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, and (iii) credit card fees.
When consumers place their orders directly on our online store, our cost of goods sold on a per-unit basis is approximately 8% lower than when consumers place their orders directly from third-party platforms.
13
We expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting demand, customer shipping costs, and management of our inventory and merchandise mix.
Over time we expect our total cost of goods sold on a per unit basis to decrease as a result of an increase in scale. Increase in scale is achieved as a result of increase in volumes from both business to consumer and business to business (retail store) orders. We continue to expand our products with line extensions and new models and broaden our presence in retail stores carrying our products.
Gross Profit and Gross Margin
We define gross profit as net revenues less cost of goods sold. Gross margin is gross profit expressed as a percentage of net revenues. Our gross margin may fluctuate in the future based on a number of factors, including the cost at which we can obtain, transport, and assemble our inventory, the rate at our vendor network expands, and how effective we can be at controlling costs, in any given period.
We anticipate our cost of goods sold, on a per unit basis, will decrease with scale, and this will likely have a positive impact on our gross margins.
Operating Expenses
Our operating expenses consist primarily of:
| ● | general & administrative expenses that include primarily consulting and payroll expenses, IT & software, legal, stock compensation expense, postage and non-customer product shipping, and other administrative expense; |
| ● | sales and marketing expenses including cost of online and TV advertising, marketing agency fees, influencers, trade shows, and other initiatives; |
| ● | related party management fees for a range of back-office services provided by Lucyd Ltd.; |
| ● | research and development expenses related to (i) development of new styles and features of our smart eyewear, (ii) development and improvement of our e-commerce website, and (iii) development of our Vyrb social media app for wearables. |
Interest and Other Income, Net
Interest and other income, net, consists primarily of interest expense paid on convertible note loan due to the Parent.
Provision for Income Taxes
Provision for income taxes consists of income taxes related to foreign and domestic federal and state jurisdictions in which we conduct business, adjusted for allowable credits, deductions, and valuation allowance against deferred tax assets.
14
Results of Operations
Three Months Ended September 30, 2022 and 2021
The following table summarizes our results of operations for the three months ended September 30, 2022 and 2021:
| Three months
ended September 30, 2022 | Three months
ended September 30, 2021 | Change between
the three months ended September 30, 2022 and 2021 | |||||||||||||||||||
| Revenues, net | $ | 151,957 | 100 | % | $ | 171,033 | 100 | % | $ | (19,076 | ) | -11 | % | ||||||||
| Less: Cost of Goods Sold | (129,092 | ) | 85 | % | (130,223 | ) | 76 | % | 1,131 | -1 | % | ||||||||||
| Gross profit/(loss) | 22,865 | 15 | % | 40,810 | 24 | % | (17,945 | ) | -44 | % | |||||||||||
| Operating Expenses: | |||||||||||||||||||||
| General and administrative | (479,983 | ) | 316 | % | (584,927 | ) | 342 | % | 104,944 | -18 | % | ||||||||||
| Sales and marketing | (568,901 | ) | 374 | % | (512,937 | ) | 300 | % | (55,964 | ) | 11 | % | |||||||||
| Research & development | (304,691 | ) | 201 | % | (9,224 | ) | 5 | % | (295,467 | ) | 3203 | % | |||||||||
| Related party management fee | (35,000 | ) | 23 | % | (25,000 | ) | 15 | % | (10,000 | ) | 40 | % | |||||||||
| Total Operating Expenses | (1,388,575 | ) | 914 | % | (1,132,088 | ) | 662 | % | (256,487 | ) | 23 | % | |||||||||
| Other Income | (735 | ) | - | (735 | ) | ||||||||||||||||
| Interest Expense | (37,876 | ) | 25 | % | (9,502 | ) | 6 | % | (28,374 | ) | 299 | % | |||||||||
| Total Other (Expense) | (38,611 | ) | 25 | % | (9,502 | ) | 6 | % | (29,109 | ) | 306 | % | |||||||||
| Net Loss | $ | (1,404,321 | ) | 924 | % | $ | (1,100,780 | ) | 644 | % | $ | (303,541 | ) | 28 | % | ||||||
Revenue
Our revenues for the three months ended September 30, 2022, were $151,957 as compared to revenues of $171,033 during the three months ended September 30, 2021. Our revenue is generated entirely from sales of eyewear products, namely smart frames, lenses, and accessories. The decrease in revenue was due to several factors, including the Company focusing more efforts on product line improvements, licensing deals and team expansion during the period, increases in digital advertising costs, and changes in consumer spending habits due to an uncertain economic climate.
For the three months ended September 30, 2022, approximately 48.9% of sales were processed on our online store (Lucyd.co), 26.1% on Amazon and 25% with reseller partners. This sales channel mix impacted our revenue for the period, due to the fact we charge additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the three months ended September 30, 2022, we generated $91,661 of revenue from sales of non-prescription frames and accessories and $22,706 was generated from sales of frames with prescription lenses. All of the $ 33,432 in sales generated on Amazon.com during the period were for non-prescription frames and accessories as we only offer prescription lenses through our website. Of the $80,934 in online sales generated through Lucyd.co, $22,706 related to frames with prescription lenses and $58,228 of glasses sold were with non-prescription lenses. E-commerce sales are the most material portion of our sales to date.
We expect that the online portion of our sales will gradually decrease on a percentage basis but remain an important component of our total sales as we onboard more retail stores. We pursued growth in retail store segment in the year ended 2021 and since the beginning of 2022, growing our retail store presence to over 200 stores as of September 30, 2022.
Cost of goods sold
Our total cost of goods sold decreased to $129,092 for the three months ended September 30, 2022, as compared to $130,222 for the three months ended September 30, 2021. The decrease being mainly attributable to a lower cost in frames. These items included, but were not limited to, the cost of frames of $89,768, cost of prescription lenses incurred with our third-party vendor of $15,482, and affiliate referral fees, sales commission expense, and e-commerce platform fees of $23,719 for the three months period ended September 30, 2022. Out of $129,092 of our total cost of goods sold for the three months ended September 30, 2022, $15,482 related to orders with prescription lenses, while $113,610 pertained to non-prescription orders.
15
Over time, we expect third-party retail stores to become our primary sales channel as we on-board additional stores. Consequently, we expect sales of prescription lens, offered through our website, to decrease as our third-party retail partners outfit our Lyte frames with more prescriptions. As a result, over time we expect prescription lens costs to gradually decrease as a percentage of our overall cost of goods sold.
We anticipate growth in both wholesale and e-commerce channel sales in the remainder of 2022 and in 2023, and we also expect corresponding growth in total cost of goods sold, primarily from additional product-related costs.
Gross profit
Our gross profit was $22,865 for the three months ended September 30, 2022, as compared to $40,810 for the three months ended September 30, 2021. This decrease was primarily due to a large number of products provided at promotional pricing to consumers and retailers to encourage market share growth, as well as increased shipping costs compared to previous years. We expect gross profit for the fiscal year ending December 31, 2022, to improve slightly, primarily due to economies of scale from large, anticipated orders. As we expect retail stores to become our primary sales channel as we onboard new stores, we also expect our overall gross margin to approximate that of the wholesale channel, where no e-commerce platform fees or prescription lens cost apply, and volume-related price discounts are included.
Operating expenses
Our operating expenses increased to $1,388,575 for the three months ended September 30, 2022, as compared to $1,132,090 for the three months ended September 30, 2021. This increase was primarily due to the expansion of our business following the launch of Lucyd Lyte in January 2021 and included, but was not limited to, the following:
General and administrative expenses
Our general and administrative expenses decreased to $479,983 for the three months ended September 30, 2022, as compared to $584,927 for the three months ended September 30, 2021. This decrease was primarily due to a reclass of stock-based compensation in the amount of $209,849 to research and development expenses. We also spent $56,000 on public & investor relations.
Sales and marketing expenses
Our sales and marketing expenses increased to $568,901 for the three months ended September 30, 2022, as compared to $512,938 for the three months ended September 30, 2021. The increase was primarily due to our multi-prong sales and marketing approach, growing continuously over 2021 and in the first quarter of 2022 after the launch of the main product in 2021, including the costs of online advertising of $217,108, influencer costs of $22,431 and trade shows of $48,680. We also hired four sales & marketing staff and booked $87,009 in related stock compensation expense for the period.
We anticipate these costs to further increase as we continue to invest in and build our brand, expand the number of e-commerce platforms we sell our products on and invest in retail store co-op marketing programs to help educate our in-store customers about Lucyd Lytes, and increase our brand’s physical presence and role in the eyewear industry.
Related party management fee
Our related party management fee was $35,000 for the three months ended September 30, 2022, as compared to $25,000 for the three months ended September 30, 2021. The increase was due to increased scope of assistances received under the agreement, corresponding to continuous scale-up of Company’s operations after launch of its flagship product in the first quarter of 2021. The management fees are related to the management services agreement between us and an affiliate of our Parent.
Research and development costs
Our research and development costs increased to $304,691 for the three months ended September 30, 2022, as compared to $9,224 for the three months ended September 30, 2021. This increase was primarily due to a reclass of stock-based compensation in the amount of $209,849 from general and administrative expenses. Also, the increased cost of new frame development by $81,485, as the Company continued to expand its product line after the flagship product was launched in the first quarter of 2021.
16
Nine Months Ended September 30, 2022 and 2021
| Nine months
ended September 30, 2022 | Nine months
ended September 30, 2021 | Change between
the six months ended September 30, 2022 and 2021 | |||||||||||||||||||
| Revenues, net | $ | 592,720 | 100 | % | $ | 415,185 | 100 | % | $ | 177,535 | 43 | % | |||||||||
| Less: Cost of Goods Sold | (452,218 | ) | 76 | % | (332,378 | ) | 80 | % | (119,840 | ) | 29 | % | |||||||||
| Gross profit/(loss) | 140,502 | 24 | % | 82,807 | 20 | % | 57,695 | 14 | % | ||||||||||||
| Operating Expenses: | |||||||||||||||||||||
| General and administrative | (1,797,091 | ) | 303 | % | (883,356 | ) | 213 | % | (913,735 | ) | 220 | % | |||||||||
| Sales and marketing | (1,545,615 | ) | 261 | % | (903,795 | ) | 218 | % | (641,820 | ) | 155 | % | |||||||||
| Research & development | (393,058 | ) | 66 | % | (36,121 | ) | 9 | % | (356,937 | ) | 86 | % | |||||||||
| Related party management fee | (105,000 | ) | 18 | % | (84,975 | ) | 20 | % | (20,025 | ) | 5 | % | |||||||||
| Total Operating Expenses | (3,840,764 | ) | 648 | % | (1,908,247 | ) | 460 | % | (1,932,517 | ) | 465 | % | |||||||||
| Other Income | (3,293 | ) | 1 | % | - | (3,293 | ) | 1 | % | ||||||||||||
| Interest Expense | (101,137 | ) | 17 | % | (33,654 | ) | 8 | % | (67,483 | ) | 16 | % | |||||||||
| Total Other (Expense) | (104,430 | ) | 18 | % | (33,654 | ) | 8 | % | (70,776 | ) | 17 | % | |||||||||
| Net Loss | $ | (3,804,692 | ) | 642 | % | $ | (1,859,094 | ) | 448 | % | $ | (1,945,598 | ) | 469 | % | ||||||
Revenue
Our revenues for the nine months ended September 30, 2022, were $592,720 as compared to revenues of $415,185 during the nine months ended September 30, 2021. Our revenue is generated entirely from sales of eyewear products, namely smart frames, lenses, and accessories. The increase in revenue was due to the launch of Lucyd Lytes in January 2021, and subsequent scale-up of sales and marketing activities leading up to more product awareness.
For the nine months ended September 30, 2022, approximately 33.6% of sales were processed on our online store (Lucyd.co), 29.6% on Amazon, and 36.8% with reseller partners. This sales channel mix impacted our revenue for the period, due to the fact we charge an additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the nine months ended September 30, 2022, we generated $460,073 of revenue from sales of non-prescription frames and accessories and $95,057 was generated from sales of frames with prescription lenses. All of the $175,269.2 in sales generated on Amazon.com during the period were for non-prescription frames and accessories as we only offer prescription lenses through our website. Of the $197,437 in online sales generated through Lucyd.co, $95,058 related to frames with prescription lenses and $102,380 of glasses sold were with non-prescription lenses. E-commerce sales are the most material portion of our sales to date.
We expect that the online portion of our sales will gradually decrease on a percentage basis but remain an important component of our total sales as we onboard more retail stores. We pursued growth in retail store segment in the year ended 2021 and during 2022, growing our retail store presence to over 200 stores as of September 30, 2022.
Cost of goods sold
Our total cost of goods sold increased to $452,218 for the nine months ended September 30, 2022, as compared to $332,378 for the nine months ended September 30, 2021. This increase mirrors the increase in underlying sales discussed above. These items included, but were not limited to, the cost of frames of $285,586, cost of prescription lenses incurred with our third-party vendor of $70,563, and affiliate referral fees, sales commission expense, and e-commerce platform fees of $93,706 for the nine months ended September 30, 2022. Out of $452,218 of our total cost of goods sold for the nine months ended September 30, 2022, $79,370 related to orders with prescription lenses, while $372,848 pertained to non-prescription orders.
For the nine months ended September 30, 2022, approximately 33.6% of sales were processed on our online store (Lucyd.co), 29.6% on Amazon, and 36.8% from reseller partners. This sales channel mix impacted our cost of goods sold, as the cost of prescription lenses attributable to our Lucyd.co sales increased our cost of goods sold through Lucyd.co while not impacting cost of goods sold for sales realized through Amazon or retail store partners.
17
Over time, we expect third-party retail stores to become our primary sales channel as we onboard additional stores. Consequently, we expect sales of prescription lens, offered through our website to decrease, as our third-party retail partners outfit our Lyte frames with more prescriptions. As a result, over time we expect prescription lens costs to gradually decrease as a percentage of our overall cost of goods sold.
We anticipate growth in both wholesale and e-commerce channel sales in the remainder of 2022 and in 2023, and we also expect corresponding growth in total cost of goods sold, primarily from additional product related costs.
Gross profit
Our gross profit increased to $140,502 for the nine months ended September 30, 2022, as compared to $82,807 for the nine months ended September 30, 2021. This increase was due to the difference in the price of Lucyd Lytes versus products available for sale in the third quarter of 2021, with new models introduced at higher prices after the first quarter of 2021. We expect gross profit for the fiscal year ending December 31, 2022, to improve slightly, primarily due to economies of scale from large, anticipated orders. As we expect retail stores to become our primary sales channel as we on board new stores, we also expect our overall gross margin to approximate that of the wholesale channel, where no e-commerce platform fees or prescription lens cost apply, and volume-related price discounts are included.
Operating expenses
Our operating expenses increased to $3,840,764 for the nine months ended September 30, 2022, as compared to $1,908,247 for the nine months ended September 30, 2021. This increase was primarily due to the expansion of our business following the launch of Lucyd Lyte in January 2021 and included, but was not limited to, the following:
General and administrative expenses
Our general and administrative expenses increased to $1,797,091 for the nine months ended September 30, 2022, as compared to $883,356 for the nine months ended September 30, 2021. This increase was primarily due to an increase of stock option awards issued in 2021, resulting from increase in our staffing of $234,522. Also, as a result of Company’s growth and increased used of consultants, consulting fees increased from $209,330 to $345,560. Further, there has been an increase Audit & Accountancy fees from $68,696 to $126,001 and we spent $56,000 on public & investor relations.
Sales and marketing expenses
Our sales and marketing expenses increased to $1,545,615 for the nine months ended September 30, 2022, as compared to $903,795 for the nine months ended September 30, 2021. The increase was primarily due to our multi-prong sales and marketing approach, growing continuously over 2021 and in the nine months of 2022 after the launch of our main product in 2021, including the costs of online advertising of $1,019,916, influencer costs of $60,113 and trade shows of $128,779. We also hired four sales & marketing staff and booked $281,953 in related stock compensation expense for the period.
We anticipate these costs to further increase as we continue to invest in and build our brand, expand the number of e-commerce platforms we sell our products on, invest in retail store co-op marketing programs to help educate our in-store customers about Lucyd Lytes, and increase our brand’s physical presence and role in the eyewear industry.
Related party management fee
Our related party management fee was $105,000 for the nine months ended September 30, 2022, as compared to $84,975 for the nine months ended September 30, 2021. The increase was due to increased scope of assistances received under the agreement, corresponding to continuous scale-up of Company’s operations after launch of its flagship product in the first quarter of 2021. The management fees are related to the management services agreement between us and an affiliate of our Parent.
Research and development costs
Our research and development costs increased to $393,058 for the nine months ended September 30, 2022, as compared to $36,121 for the nine months ended September 30, 2021. The increase was primarily due to a reclass of stock-based compensation in the amount of $209,849 from general and administrative expenses in addition to the increased cost of new frame development as the Company continued to expand its product line after the flagship product was launched in the first quarter of 2021.
18
Liquidity and Capital Resources
Cash Flow Data:
| Nine months ended | Nine months ended | |||||||
| September 30, | September 30, | |||||||
| 2022 | 2021 | |||||||
| Net cash flows from operating activities | $ | (1,995,678 | ) | $ | (810,446 | ) | ||
| Net cash flows from investing activities | (155,428 | ) | (87,246 | ) | ||||
| Net cash flows from financing activities | 7,047,603 | 935,725 | ||||||
| Net Change in Cash | $ | 4,896,497 | $ | 38,033 | ||||
Initial Public Offering
On August 17, 2022, the Company closed on its initial public offering of 980,000 units, consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock, at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants, each warrant to purchase one share of common stock at an exercise price of $7.50 per share. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock.
After deducting underwriting discounts and offering expenses, net proceeds received by the Company amounted to $6,189,734. We intend to use proceeds from this offering primarily on (i) sales and marketing, (ii) expanding our inventory, (iii) updating and developing our in-store displays, (iv) developing new smart eyewear styles and sizes, as well as further development and commercialization of the Vyrb app, and (v) working capital and other general corporate purposes.
We expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. We believe our existing cash and cash equivalents, proceeds from the aforementioned offering, funds available under our existing credit facility, and cash flows from operating activities will be sufficient to fund our operations for at least the next twelve months.
However, our future capital requirements will depend on many factors, including, but not limited to, growth in the number of retail store customers, the needs of our e-commerce business and retail distribution network, expansion of our product and software offerings, and the timing of investments in technology and personnel to support the overall growth of our business. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our stockholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations. There can be no assurances that we will be able to raise additional capital. In the event that additional financing is required from outside sources, we may not be able to negotiate terms acceptable to us or at all. The recent COVID-19 pandemic along with other geopolitical and macroeconomic factors has caused disruption in the global financial markets, which could reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to raise additional capital when required, or if we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, results of operations, financial condition, and cash flows would be adversely affected.
Off-Balance Sheet Arrangements
As of September 30, 2022, we did not have any off-balance sheet arrangements.
19
Critical Accounting Policies and Significant Developments and Estimates
Management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods, as well as related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the amount of revenue and expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.
We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically re-evaluate these accounting policies and estimates and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.
Inventory
Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed at September 30, 2022 and as of December 31, 2021.
As of September 30, 2022 and December 31, 2021, the Company recorded an inventory prepayment in the amount of $197,750 and $64,715, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after September 30, 2022 and December 31, 2021, respectively.
Intangible Assets
Intangible assets relate to:
| ● | Internally-developed and licensed utility and design patents. We amortize these assets over the estimated useful life of the patents. |
| ● | Capitalized software costs incurred due to development of the Vyrb app. We amortize these assets over the estimated useful life of the software application. |
We review our intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.
Income Taxes
We are taxed as a C corporation. We comply with Financial Accounting Standards Board (FASB) ASC 740 for accounting for uncertainty in income taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, and disclosure. Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our financial statements. We believe that our income tax positions would be sustained on audit and do not anticipate any adjustments that would result in a material change to the Company’s financial position.
We have incurred taxable losses since inception but are current in our tax filing obligations. We are not presently subject to any income tax audit in any taxing jurisdiction.
20
Stock-Based Compensation
We account for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).
The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.
The fair value of common stock used in the option pricing model in 2020 and 2021 was determined using the most recent price paid by independent investors through Regulation Crowdfund (“REG CF”) securities offerings undertaken by the Company. For a majority of the time during which stock option awards were granted by the Company in 2021 and 2020, the Company had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors. Specifically, (i) from June 2020 to April 2021, the Company was conducting a REG CF offering of its shares of common stock at a price of $1 per share, and the Company utilized this $1 per share price to issue and value its stock-based awards during such period, and (ii) from May 2021 to September 2021, the Company was conducting a second REG CF offering of its shares of common stock at a price of $3.56 per share, and the Company utilized this $3.56 per share price to issue and value its stock-based awards during such period.
The pre-money valuation determining price per share was agreed upon each time with the crowdfund platform, who has great deal of experience in setting the proper pre-money valuations for companies that list on their platforms. The determination was made using Company’s business progress.
Revenue Recognition
Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, and on our own website Lucyd.co and on Amazon.
To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract, determine those that are performance obligations, and assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.
All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.
For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.
21
For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation which is delivery of our eyewear products to the retail store and also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.
For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.
The Company’s sales to both retail partners and through our e-commerce channels do not contain any variable consideration.
We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:
| ● | 7 days for sales made through our website (Lucyd.co) |
| ● | 30 days for sales made through Amazon |
| ● | 30 days for sales to wholesale retailers and distributors |
For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we reviewed all individual returns received in October 2022 pertaining to orders processed prior to September 30, 2022. As a result, the Company determined that an allowance for sales returns was necessary. The Company recorded $22,266 in allowance for sales returns as of December 31, 2021 and $12,604 as of September 30, 2022.
Shipping and Handling
Costs incurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.
Earnings/loss per share
The Company presents earnings and loss per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the period as required by ASC 260-10-50. As of September 30, 2022 and December 31, 2021, all shares underlying the related party convertible debt and common stock options were excluded from the earnings per share calculation, due to their anti-dilutive effect.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
This quarterly report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the company’s registered public accounting firm due to a transition period established by rules of the Securities and Exchange Commission for newly public companies.
22
Part II. Other Information
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
There have been no material changes in our risk factors from those disclosed in our Registration Statement on Form S-1, which was declared effective by the SEC on August 12, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On August 17, 2022, we consummated our initial public offering of 980,000 units at a price to the public of $7.50 per unit, each unit consisting of one share of the Company’s common stock, par value $0.00001 per share (the “Common Stock”) and two warrants (the “Warrants”), with each Warrant exercisable to acquire one share of common stock, pursuant to that certain underwriting agreement, dated as of August 14, 2022 (the “Underwriting Agreement”), between the Company and Maxim Group LLC, as representative (the “Representative”) of the several underwriters named in the Underwriting Agreement for aggregate gross proceeds of approximately $7,350,000. In addition, pursuant to the Underwriting Agreement, the Company granted the Representative a 45-day option to purchase up to 147,000 additional shares of Common Stock, and/or up to 294,000 additional Warrants, to cover over-allotments in connection with the offering, which the Representative partially exercised to purchase 294,000 Warrants.
The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-261616). The SEC declared the registration statement effective on August 12, 2022.
Of the gross proceeds received from the initial public offering, we received approximately $6.1 million, and we paid a total of approximately $588,000 in underwriting discounts and commissions and $600,000 for other costs and expenses related to the initial public offering.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
None.
23
Item 6. Exhibits
24
Signatures
Pursuant to the requirements of the Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Innovative Eyewear, Inc. | ||
| (Registrant) | ||
| Date: November 10, 2022 | By: | /s/ Harrison Gross |
| Harrison Gross | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| Date: November 10, 2022 | By: | /s/ Konrad Dabrowski |
| Konrad Dabrowski | ||
| Chief Financial Officer | ||
| (Principal Financial Officer and Principal Accounting Officer) | ||
25
Exhibit 31.1
CERTIFICATIONS
I, Harrison Gross, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of Innovative Eyewear, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of a quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: November 10, 2022 | By: | /s/ Harrison Gross |
| Harrison Gross | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |
Exhibit 31.2
CERTIFICATIONS
I, Konrad Dabrowski, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of Innovative Eyewear, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of a quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: November 10, 2022 | By: | /s/ Konrad Dabrowski |
| Konrad Dabrowski | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Innovative Eyewear, Inc. (the “Company”) for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Harrison Gross, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| 2. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the report. |
| Date: November 10, 2022 | By: | /s/ Harrison Gross |
| Harrison Gross | ||
| Chief
Executive Officer (Principal Executive Officer) |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Innovative Eyewear, Inc. (the “Company”) for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Konrad Dabrowski, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| 2. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the report. |
| Date: November 10, 2022 | By: | /s/ Konrad Dabrowski |
| Konrad Dabrowski | ||
| Chief
Financial Officer (Principal Financial and Accounting Officer) |